692
Views
25
CrossRef citations to date
0
Altmetric
Review

Treatment development for psychosis and co-occurring substance misuse: A descriptive review

, , &
Pages 619-632 | Published online: 06 Jul 2009

References

  • Addington J. An integrated treatment approach to substance use in an early psychosis programme. Substance misuse in psychosis: Approaches to treatment and service delivery, H. L. Graham, et al. John Wiley & Sons, ChichesterUK 2003
  • American Psychiatric Association. Global assessment of functioning scale. Author, Washington, DC 1994
  • Baker A., Lewin T., Reichler H., Clancy R., Carr V., Garrett R., et al. Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction 2002; 97: 1329–1337
  • Baker A., Bucci S., Lewin T. J., Kay-Lambkin F., Constable P. M., Carr V. J. Randomised controlled trial of cognitive behaviour therapy for substance use disorders among people with a psychotic illness. British Journal of Psychiatry, in press
  • Barrowclough C., Haddock G., Tarrier N., Lewis S. W., Moring J., O'Brien R., et al. Randomised controlled trial of cognitive behavioural therapy plus motivational intervention for schizophrenia and substance use. American Journal of Psychiatry 2001; 158: 1706–1713
  • Barrowclough C., Tarrier N., Humphreys L., Ward J., Gregg L., Andrews B. Self esteem in schizophrenia: The relationship between self evaluation, family attitudes and symptomatology. Journal of Abnormal Psychology 2003; 112: 92–99
  • Barrowclough C., Haddock G., Lowens I., . Psychosis & drug and alcohol problems. Clinical Handbook of co-existing mental health and drug and alcohol problems, Baker, Velleman, et al
  • Birchwood M., Smith J., Cochrane R., Wetton S., Copestake S. The Social Functioning Scale: The development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry 1990; 157: 853–859
  • Burnham M. A., Morton S. C., McGlynn E. A., Peterson L. P., Stecher B. M., Hayes C., et al. An experimental evaluation of residential and non residential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases 1995; 14: 111–134
  • Blanchard J. J., Brown S. A., Horan W. P., Sherwood A. Substance use disorders in schizophrenia: Review, integration and a proposed model. Clinical Psychology Review 2000; 20: 207–234
  • Brunette M., Mueser K., Xie H., Drake R. Relationships between symptoms of schizophrenia and substance abuse. Journal of Nervous and Mental Disease 1997; 185: 251–257
  • Butzlaff R. L., Hooley J. Expressed emotion and psychiatric relapse: A meta-analysis. Archives of General Psychiatry 1998; 55: 547–552
  • Carey K. B., Carey M. P. Reasons for drinking among psychiatric outpatients: Relationship to drinking patterns. Psychology of Addictive Behaviours 1995; 9: 251–257
  • Chambers R. A., Krystal J. H., Self D. W. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry 2001; 50: 71–83
  • Conrod P. J., Stewart S. H. A critical look at dual-focused cognitive-behavioral treatments for comorbid substance use and psychiatric disorders: Strengths, limitations, and future directions. Journal of Cognitive Psychotherapy: An International Quarterly 2005; 19: 265–289
  • Department of Health. Dual Diagnosis Good Practice Guide. DH Publications. 2002, Policy and Guidance Article (www.dh.gov.uk)
  • Drake R. E., McHugo G. H., Clark R. E., Teague G. B., Xie H., Miles K., et al. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: A clinical trial. American Journal of Orthopsychiatry 1998; 68: 201–215
  • Drake R. E., Yovetich N. A., Bebout R. R., Harris M., McHugo G. H. Integrated treatment for dually diagnosed homeless adults. Journal of Nervous and Mental Disease 1997; 185: 298–305
  • Drake R. E., Mercer-McFadden C., Mueser K. T., McHugo G. J., Bond G. R. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin 1998; 24: 589–608
  • Drake R. E., Mueser K. T., Brunette M. F., McHugo G. J. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal 2004; 27: 360–374
  • Drake R. E., Osher F. C., Wallach M. A. Alcohol use and abuse in schizophrenia: A prospective community study. Journal of Nervous and Mental Disease 1989; 177: 408–414
  • Edwards J., Hinton M., Elkins K., Athanasopoulos O. Cannabis and first episode psychosis: The CAP project. Substance misuse in psychosis: Approaches to treatment and service delivery, H. L. Graham, et al. John Wiley & Sons, ChichesterUK 2003
  • Godley S. H., Hoewing-Roberson R., Godley R. Final MISA Report. Lighthouse Institute, Bloomington, IL 1994
  • Graham H. L., Copello A., Birchwood M. J., Maslin J., McGovern D., Orford J., . The combined psychosis and substance use (COMPASS) programme: An integrated, shared care approach. Substance misuse in psychosis: Approaches to treatment and service delivery, H. L. Graham, et al. John Wiley & Sons, ChichesterUK 2003
  • Graeber D. A., Moyers T. B., Griffiths G., Guajardo E., Tonigan S. A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal 2003; 39: 189–202
  • Haddock G., Barrowclough C., Tarrier N., Moring J., et al. Randomised controlled trial of cognitive-behaviour therapy and motivational intervention for schizophrenia and substance use: 18 month, carer and economic outcomes. British Journal of Psychiatry 2003; 183: 418–426
  • Handmaker N., Packard M., Conforti K. Motivational interviewing in the treatment of dual disorders. Motivational interviewing: Preparing people for change (2nd ed.), W. R. Miller, S. Rollnick. Guilford Press, New York 2002
  • James W., Preston N. J., Koh G., Spencer C., Kisely S. R., Castle D. J. A group intervention which assists patients with dual diagnosis reduce their drug use: A randomized controlled trial. Psychological Medicine 2004; 34: 983–990
  • Kavanagh D. J., Waghorn G., Jenner L., Chant D. C., Carr V., Evans M., et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample. Schizophrenia Research 2004; 66: 115–124
  • Kavanagh D. J., Young R., White A., Saunders J. B., Shockley N., Wallis J., . Start over and survive: A brief intervention for substance misuse in early psychosis. Substance misuse in psychosis: Approaches to treatment and service delivery, H. L. Graham, et al. John Wiley & Sons, ChichesterUK 2003
  • Kay S., Fiszbein A., Opler L. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1988; 13: 261–275
  • Ley A., Jeffery D. Cochrane review of treatment outcome studies and its implications for future development. Substance misuse in psychosis: Approaches to treatment and service delivery, H. L. Graham, et al. John Wiley & Sons, ChichesterUK 2003
  • Marlatt G. A., Gordon J. R. Relapse prevention: Maintenance strategies in the treatment of addictive behaviours. Guilford Press, New York 1985
  • Martino S., Carroll K., Kostas D., Perkins J., Rounsaville B. Dual diagnosis motivational interviewing: A modification of motivational interviewing for substance abusing patients with psychotic disorders. Journal of Substance Abuse Treatment 2002; 23: 297–308
  • Maslin J. Substance misuse in psychosis: Contextual issues. Substance misuse in psychosis: Approaches to treatment and service delivery, H. L. Graham, et al. John Wiley & Sons, ChichesterUK 2003
  • Miller W. R., Rollnick S. Motivational interviewing: Preparing people for change (2nd ed.). Guilford Press, New York 2002
  • Mueser K. T., Bennet M., Kushner M. G. Epidemiology of substance use disorders among persons with chronic mental illnesses. Double-jeopardy: Chronic mental illness and substance use disorders, A. F. Lehman, L. B. Dixon. Harwood, Langhorne, PA 1995
  • Mueser K. T., Drake R. E. Integrated dual diagnosis treatment in New Hampshire (USA). Substance misuse in psychosis: Approaches to treatment and service delivery, H. L. Graham, et al. John Wiley & Sons, ChichesterUK 2003
  • Mueser K. T., Drake R. E., Sigmon S. C., Brunette M. F. Psychosocial interventions for adults with severe mental illnesses and co-occurring substance use disorders: A review of specific interventions. Journal of Dual Diagnosis 2005; 1: 57–82
  • Mueser K. T., Nishith P., Tracy J. I., DeGirolamo J., Molinaro M. Expectations and motives for substance use in schizophrenia. Schizophrenia Bulletin 1995; 21: 367–378
  • Patkar A. A., Alexander R. C., Lundy A., Certa K. M. Changing patterns of illicit substance use among schizophrenic patients. American Journal of Addiction 1999; 8: 65–71
  • Pilling S., Bebbington P., Kuipers E., Garety P., Geddes J., Orbach G., et al. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine 2002; 32: 763–782
  • Regier D. A., Farmer M. F., Rae D. S., Locke B. Z., Keith S. J., Judd L. L., et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511–2518
  • Schneier F. R., Siris S. G. A review of psychoactive substance use and abuse in schizophrenia: Patterns of drug choice. Journal of Nervous and Mental Disease 1987; 175: 641–652
  • Sobell L. C., Sobell M. B. Time Line Follow Back (TLFB): A technique for assessing self-reported alcohol consumption. Measuring alcohol consumption, R. Litten, J. Allen. Humana Press Inc., Totowa, NJ 1992
  • Stewart S. H., Conrod P. J. Introduction to the special issue on state-of-the-art cognitive-behavioral interventions for substance use disorders. Journal of Cognitive Psychotherapy: An International Quarterly 2005; 19: 195–198
  • Swanson A. J., Pantalon M. V., Cohen K. R. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. The Journal of Nervous and Mental Disease 1999; 187: 630–635
  • Teeson M., Hall W., Lynskey M., Degenhardt L. Alcohol and drug use disorders in Australia: Implications of the National Survey of Mental Health and Well Being. Australia New Zealand Journal of Psychiatry 2000; 34: 206–213
  • Weaver T., Madden P., Charles V., Stimson G., Renton A., Tyrer P., et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry 2003; 183: 304–313
  • Verdoux H., Gindre C., Sorbara F., Ttournier M., Swendsen J. D. Effects of cannabis psychosis vulnerability in daily life: An experience sampling test study. Psychological Medicine 2003; 33: 23–32
  • Weaver T., Rutter D., Madden P., Ward J., Stimson G., Renton A. Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: Prevalence and service needs in an inner London borough. Social Psychiatry and Psychiatric Epidemiology 2001; 36: 399–406
  • Ziedonis D. M., Smelson D., Rosenthal R. N., Batki S. L., Green A. L., Henry R. J., et al. Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations. Journal of Psychiatric Practice 2005; 11: 315–406

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.